Skip to content

Research on the Construction of a clinical efficacy prediction Model for Baihui Shiyan Moxibustion in the Treatment of Mild Cognitive Impairment in Cerebral Small Vessel Disease of Qi Deficiency and Blood Stasis Type Based on Machine Learning Technology

Research on the Construction of a clinical efficacy prediction Model for Baihui Shiyan Moxibustion in the Treatment of Mild Cognitive Impairment in Cerebral Small Vessel Disease of Qi Deficiency and Blood Stasis Type Based on Machine Learning Technology

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000438
Enrollment
Unknown
Registered
2026-03-03
Start date
2025-12-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral small vessel disease

Interventions

Experimental Group:Baihui Shiyan moxibustion was given on the basis of conventional internal medicine basic treatment

Sponsors

Fujian University of Traditional Chinese Medicine Affiliated Rehabilitation Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Those who meet the diagnostic criteria for mild cognitive impairment due to cerebral small vessel disease in both Chinese and Western medicine, and have a Montreal Cognitive Assessment (MoCA) score between 19 and 25 points; 2) Aged 50 to 80 years, with no gender restrictions; 3) Have not received any treatment related to this disease in the past month; 4) Stable condition, clear consciousness, and able to cooperate with assessment and treatment; 5) Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Excluding other imaging changes or diseases that can explain memory or other cognitive impairments, such as: no cortical and/or subcortical non-lacunar infarction, cerebral hemorrhage; 2) Special causes of white matter (multiple sclerosis, brain radiotherapy, etc.); 3) Brain lesions (such as Alzheimer's disease, tumors, etc.); 4) Severe mental illness and epilepsy, alcohol and drug abuse, poisoning and metabolic abnormalities, etc.; 5) Suffering from severe organ failure, severe cardiovascular and cerebrovascular diseases, malignant tumors, etc., which cannot ensure the successful completion of the trial; 6) Presence of severe neurological deficits such as aphasia and temperature sensation disorders; 7) Pregnant women and lactating women; 8) Those allergic to the items used in the therapy or with local skin damage at the moxibustion site; 9) Other situations not suitable for moxibustion treatment.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment;Vascular Dementia Assessment Scale;

Secondary

MeasureTime frame
Trail Making Test;Digit Span Test;Traditional Chinese Medicine Syndrome Score;Auditory word learning test;resting-state functional magnetic resonance imaging;

Countries

China

Contacts

Public ContactWanqing Lin

Fujian University of Traditional Chinese Medicine Affiliated Rehabilitation Hospital

13960829639@139.com13960829639

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026